This is the authors' abstract. We don't add key points for this paper.
At present, taking into account the widespread application of pharmacogenetics’ achievements to all branches of medicine, it has become possible to conduct such research in ophthalmology. At the moment, the studies on the most broadly used glaucoma medications have been carried out. The correlations between patients’ genotypes and the frequency of occurrence of adverse side effects have been found. The further exploration of the pharmacogenetics of the glaucoma medications and the introduction of pharmacogenetic testing will enable ophthalmologists to assign a rational, safe, and effective treatment in the short time, which will considerably improve the quality of provided aid.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Moshetova et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: